Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00022464 · ClinicalTrials.gov registry record · Phase 2
CCI-779 in Treating Patients With Metastatic Melanoma
A Phase 2 study, sponsored by City of Hope Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
NCT00022464: Completed Phase 2 study, sponsored by City of Hope Medical Center.
NCT00022464 is a Phase 2 study that has completed, run by City of Hope Medical Center. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00022464, a Phase 2 study, has completed, sponsored by City of Hope Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
Study Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of CCI-779 in treating patients who have metastatic melanoma.
Interventions
- DRUG temsirolimus
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-06 |
| Est. Completion | 2005-09 |
| Phase | Phase 2 |
What the finished NCT00022464 record still lists
NCT00022464 is an interventional study that assigns participants to a tested intervention. An enrollment target was not published in the registry record, which is common for early-stage or observational entries.
The record links to 0 conditions, and to 1 intervention - of which temsirolimus is the first listed.
NCT00022464 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00022464 about?
NCT00022464 is a clinical study titled "CCI-779 in Treating Patients With Metastatic Melanoma". RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of CCI-779 in treating patients who have metastatic melanoma.
What is the current status of trial NCT00022464?
This trial is currently completed. It is a Phase 2 study. The study started on 2001-06. Estimated completion is 2005-09.
What interventions are being tested in trial NCT00022464?
The interventions under investigation include: temsirolimus (DRUG).
Who is sponsoring clinical trial NCT00022464?
This trial is sponsored by City of Hope Medical Center, which has 582 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia